Ensysce Biosciences, Inc. (ENSC) Q1 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ensysce Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:03.774 Good morning and welcome to the Insights Biosciences, Biosciences, Inc. 00:00:03.774 -- 00:00:08.801 Corporate Update Call. As a reminder, this conference is being recorded. 00:00:08.801 -- 00:00:13.767 Your hosts today are Dr. Lynn Kirkpatrick, Chief Executive Officer, and Dave Humphrey, 00:00:13.767 -- 00:00:18.778 Chief Financial Officer. Before we begin the formal presentation, I would like to remind 00:00:18.778 -- 00:00:22.999 everyone that statements made on the call and webcast may include predictions, estimates, 00:00:22.999 -- 00:00:26.321 or other information that might be considered forward-looking. 00:00:26.321 -- 00:00:29.802 While these forward-looking statements represent our current judgment on what the future 00:00:29.802 -- 00:00:34.063 holds, they are subject to risks and uncertainties that could cause actual results to 00:00:34.063 -- 00:00:38.645 differ materially. You are cautioned not to place undue reliance on these forward-looking 00:00:38.645 -- 00:00:43.769 statements which reflect our opinions only as of the date of this presentation. 00:00:43.769 -- 00:00:47.693 Please keep in mind that we are not obligating ourselves to revise or publicly release 00:00:47.693 -- 00:00:51.756 the results of any revision to these forward-looking statements in light of new information 00:00:51.756 -- 00:00:56.240 or future events. Throughout today's discussion, we will attempt to present some important 00:00:56.240 -- 00:01:00.004 factors relating to our business that may affect our predictions. 00:01:00.004 -- 00:01:05.769 You should also review our most recent forms, 10-Q and 10-K, for a more complete discussion 00:01:05.769 -- 00:01:10.566 of these factors and other risks, particularly under the heading risk factors. ...